F.D.A. Still Lacks a Permanent Commissioner

With the pandemic easing, the federal agency’s long-term agenda for drug approvals or new issues is languishing without a permanent commissioner.

#aduhelm-drug, #biden-joseph-r-jr, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #food, #food-and-drug-administration, #smoking-and-tobacco, #united-states-politics-and-government, #woodcock-janet, #your-feed-healthcare

0

Three F.D.A. Advisers Resign Over Agency’s Approval of Alzheimer’s Drug

The drug, Aduhelm, a monthly infusion priced at $56,000 per year, was approved this week despite weak evidence that it helps patients.

#aduhelm-drug, #alzheimers-disease, #biogen-inc, #clinical-trials, #drugs-pharmaceuticals, #elderly, #your-feed-science

0